Kenji Fukunaga

Kenji Fukunaga

Fortune : 252 567 $ au 31/07/2026

57 ans
Commercial Services
Health Technology
Distribution Services

Profil

Kenji Fukunaga is currently President & Representative Director at Trans Genic Group, Inc. since 2010, Primmune Inc since 2011, New Drug Research Center Inc. since 2013, TG Business Service, Inc. since 2017, Biosafety Research Center, Inc. since 2018, and Galax Corp.
He is also an Outside Director at Immuno-Biological Laboratories Co., Ltd. since 2011.
Former positions include Director at Trans Genic Group, Inc. from 2009 to 2010, Director at Tohmatsu Venture Support Co., Ltd., and President & Representative Director at Eurofins Genetic Lab KK from 2019 to 2022.

Détentions connues dans des sociétés publiques

SociétéDateNombre d'actionsValorisationDate de valorisation
31/03/2026 191 500 ( 1,13% ) 252 567 $ 31/07/2026

Postes actifs de Kenji Fukunaga

SociétésPosteDébut
IMMUNO-BIOLOGICAL LABORATORIES CO., LTD. Directeur/Membre du Conseil 01/06/2011
TRANSGENIC GROUP INC. President 01/06/2010
President 01/04/2011
President 01/04/2013
President 01/11/2017
President 01/03/2018
President -

Anciens postes connus de Kenji Fukunaga

SociétésPosteFin
President 01/01/2022
Tohmatsu Venture Support Co., Ltd.
Directeur/Membre du Conseil -
░░░░░░░░░░ ░░░░░ ░░░░ ░░░░░░░░░ ░░░░░░░░░ -
Voir l'expérience en détail de Kenji Fukunaga

Expériences
Fonctions occupées

Actives

Inactives

Sociétés cotées

Entreprise privées

Relations

19

Relations au 1er degré

9

Entreprises liées au 1er degré

Homme

Femme

Administrateurs

Exécutifs

Sociétés liées

Entreprise privées9

Health Technology

Health Technology

Health Technology

Tohmatsu Venture Support Co., Ltd.

Commercial Services

Commercial Services

Commercial Services

Commercial Services

Distribution Services

  1. Bourse
  2. Insiders
  3. Kenji Fukunaga